Haiwen & Partners is sought out by biotechnology, medical device, cosmetic and health food clients for its corporate, IP and regulatory expertise that tackles all aspects of issues that arise from the entire product life cycle. The team is led by Tina Wu, adept in licensing, regulatory and compliance work concerning clinical research, product development and licensing deals. Rui Feng excels in M&A, corporate and regulatory compliance, while IP specialist Frank Wang is noted for patent examination matters and IP litigation. Xiaobin Zhu focuses on private equity and venture capital investments. Wenzhen Dai is a key M&A lawyer in the medical sector.
Legal 500 Editorial commentary
Key clients
- New Frontier Group
- Wuxi Innovation Investment Group
Work highlights
Assisting Zhiyuanbaimai (Hangzhou) Technology Co., Ltd. with minority equity investment project.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Tina Wu
Other key lawyers
Rui Feng; Frank Wang; Wenzhen Dai; Xiaobin Zhu